Scilex (NASDAQ:SCLX) Trading Down 6.8%
Scilex (NASDAQ:SCLX) Trading Down 6.8%
Scilex Holding (NASDAQ:SCLX – Get Rating) was down 6.8% during trading on Tuesday . The company traded as low as $7.70 and last traded at $8.10. Approximately 87,227 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 509,121 shares. The stock had previously closed at $8.69.
Scilex Stock Down 9.8 %
The stock has a 50-day moving average of $5.36.
About Scilex
(Get Rating)
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain. Its commercial product is ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain.
Featured Articles
- Get a free copy of the StockNews.com research report on Scilex (SCLX)
- Will Caterpillar Dig Its Way To Another Buying Opportunity?
- United Parcel Service Delivers Shareholder Value
- Will McDonald's Stock Hit an All-Time HIgh After Earnings?
- Carvana Is Up 39.28% In One Week: Is It The Newest Meme Stock?
- Whirlpool Corporation: High-Yield Value Spins Back Into Style
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
Scilex Holding (NASDAQ:SCLX – Get Rating) was down 6.8% during trading on Tuesday . The company traded as low as $7.70 and last traded at $8.10. Approximately 87,227 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 509,121 shares. The stock had previously closed at $8.69.
Scilex Holding（纳斯达克股票代码：SCLX — 获取评级）在周二的交易中下跌了6.8％。该公司的交易价格低至7.70美元，最后一次交易价格为8.10美元。午盘交易中约交易了87,227股，较平均每日交易量509,121股下降了83％。该股此前收于8.69美元。
Scilex Stock Down 9.8 %
Scilex 股价下跌 9.8%
The stock has a 50-day moving average of $5.36.
该股的50天移动平均线为5.36美元。
About Scilex
关于 Scilex
(Get Rating)
（获取评分）
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain. Its commercial product is ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain.
Scilex Holding Company是一家生物制药公司，专注于开发和商业化用于治疗急性和慢性疼痛的非阿片类药物管理产品。其商业产品为ztLido 1.8％，这是一种处方利多卡因局部产品，用于缓解与疱疹后神经痛相关的神经病理性疼痛，疱疹后神经痛是一种带状疱疹后神经痛。
Featured Articles
精选文章
- Get a free copy of the StockNews.com research report on Scilex (SCLX)
- Will Caterpillar Dig Its Way To Another Buying Opportunity?
- United Parcel Service Delivers Shareholder Value
- Will McDonald's Stock Hit an All-Time HIgh After Earnings?
- Carvana Is Up 39.28% In One Week: Is It The Newest Meme Stock?
- Whirlpool Corporation: High-Yield Value Spins Back Into Style
- 免费获取 StockNews.com 关于 Scilex (SCLX) 的研究报告的副本
- 卡特彼勒会挖掘另一个买入机会吗？
- 联合包裹服务为股东带来价值
- 麦当劳的股票在盈利后会创下历史新高吗？
- Carvana 在一周内上涨了 39.28%：它是最新的 Meme 股票吗？
- 惠而浦公司：高收益价值回归时尚
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Scilex Daily 的新闻和评级 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收Scilex及相关公司的最新新闻和分析师评级的简明每日摘要。
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧